Found: 15
Select item for more details and to access through your institution.
Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.797589
- By:
- Publication type:
- Article
Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired Immunity: A Comparison of Three COVID-19 Vaccines.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2152, doi. 10.3390/vaccines10122152
- By:
- Publication type:
- Article
Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 1, p. 467, doi. 10.1093/rheumatology/keac322
- By:
- Publication type:
- Article
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 631, p. 1, doi. 10.1126/scitranslmed.abi8961
- By:
- Publication type:
- Article
Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study.
- Published in:
- Annals of Neurology, 2022, v. 91, n. 6, p. 782, doi. 10.1002/ana.26346
- By:
- Publication type:
- Article
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS–CoV‐2 Vaccination.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 2, p. 284, doi. 10.1002/art.41937
- By:
- Publication type:
- Article
Generation of quality-controlled SARS-CoV-2 variant stocks.
- Published in:
- Nature Protocols, 2023, v. 18, n. 12, p. 3821, doi. 10.1038/s41596-023-00897-6
- By:
- Publication type:
- Article
Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 7, p. 1750, doi. 10.1002/acn3.52081
- By:
- Publication type:
- Article
Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 10, p. 1643, doi. 10.1002/acn3.51664
- By:
- Publication type:
- Article
Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84913-3
- By:
- Publication type:
- Article
SARS-CoV-2 inflammation durably imprints memory CD4 T cells.
- Published in:
- Science Immunology, 2024, v. 9, n. 96, p. 1, doi. 10.1126/sciimmunol.adj8526
- By:
- Publication type:
- Article
Immunogenicity after heterologous third dose COVID‐19 vaccination in a heart transplant recipient.
- Published in:
- Clinical Transplantation, 2022, v. 36, n. 4, p. 1, doi. 10.1111/ctr.14605
- By:
- Publication type:
- Article
Interplay of Trypanosome Lytic Factor and innate immune cells in the resolution of cutaneous Leishmania infection.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 9, p. 1, doi. 10.1371/journal.ppat.1008768
- By:
- Publication type:
- Article
ESTABLISHING AN OBSERVATIONAL MPOX VACCINATION STUDY WHILE THE OUTBREAK EVOLVES.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 400
- By:
- Publication type:
- Article
Trypanosome Lytic Factor, an Antimicrobial High-Density Lipoprotein, Ameliorates Leishmania Infection.
- Published in:
- PLoS Pathogens, 2009, v. 5, n. 1, p. 1, doi. 10.1371/journal.ppat.1000276
- By:
- Publication type:
- Article